HLTX-2

Obesity is a significant global health challenge that has far-reaching implications for individuals, healthcare systems, and economies worldwide. The global market for anti-obesity medications is anticipated to grow by 15-20 fold by 2031, to over $100 billion.

To develop HLTX-2 we have targeted the signaling pathways between the gut and the brain that drive appetite.